Overview
Research | Process | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | ||
---|---|---|---|---|---|---|---|
ALT-P1 | Long-acting Human Growth Hormone | ![]() |
![]() |
![]() |
![]() |
![]() |
|
Domestic Phase II in Progress / Preparation of global Phase II | |||||||
ALT-P7 | Breast/Gastric Cancer ADC | ![]() |
![]() |
![]() |
![]() |
||
Domestic Phase I completed | |||||||
ALT-L9 | Eylea Biosimilar | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Global Phase III Clinical Trial in Progress | |||||||
ALT-L2 | Herceptin Biosimilar | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
BLA in China |
